Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker for prostate cancer

PURPOSE: To explore the mechanisms of radiotherapy resistance and search for prognostic biomarkers for prostate cancer. METHODS: The GSE192817 and TCGA PRAD datasets were selected and downloaded from the GEO and UCSC Xena databases. Differential expression and functional annotation analyses were app...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xing, Yu, Jiandi, Wen, Huali, Yan, Junfeng, Peng, Kun, Zhou, Haiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507967/
https://www.ncbi.nlm.nih.gov/pubmed/37726767
http://dx.doi.org/10.1186/s12894-023-01319-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507967/
https://www.ncbi.nlm.nih.gov/pubmed/37726767
http://dx.doi.org/10.1186/s12894-023-01319-1

Ejemplares similares